User profiles for Adalbert Krawczyk
 | Adalbert KrawczykUniversity of Duisburg-Essen, Department of Infectious Diseases Verified email at uni-due.de Cited by 3726 |
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
…, B Wilde, S Dolff, OE Anastasiou, A Krawczyk… - Journal of Clinical …, 2020 - Elsevier
Background The novel coronavirus SARS-CoV-2 is associated with a severe respiratory
manifestation, COVID-19, and presents a challenge for healthcare systems worldwide. …
manifestation, COVID-19, and presents a challenge for healthcare systems worldwide. …
[HTML][HTML] Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease
…, D Todt, U Dittmer, C Elsner, O Witzke, A Krawczyk - Viruses, 2021 - mdpi.com
The outbreak of SARS-CoV-2 developed into a global pandemic affecting millions of people
worldwide. Despite one year of intensive research, the current treatment options for SARS-…
worldwide. Despite one year of intensive research, the current treatment options for SARS-…
Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
creates a significant threat to global health. Recent studies suggested the significance of throat …
creates a significant threat to global health. Recent studies suggested the significance of throat …
Susceptibility of SARS-CoV-2 to UV irradiation
…, M Trilling, M Alt, E Steinmann, A Krawczyk - American journal of …, 2020 - Elsevier
The coronavirus SARS-CoV-2 pandemic became a global health burden. We determined
the susceptibility of SARS-CoV-2 to irradiation with ultraviolet light. The virus was highly …
the susceptibility of SARS-CoV-2 to irradiation with ultraviolet light. The virus was highly …
[HTML][HTML] SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
…, H Wang, S Li, S Lu, D Liu, H Li, A Krawczyk… - Nature …, 2021 - nature.com
Long-term antibody responses and neutralizing activities in response to SARS-CoV-2
infection are not yet clear. Here we quantify immunoglobulin M (IgM) and G (IgG) antibodies …
infection are not yet clear. Here we quantify immunoglobulin M (IgM) and G (IgG) antibodies …
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 …
…, P Schmid, F Le Gal, E Gordien, A Krawczyk… - The lancet …, 2017 - thelancet.com
Background REP 2139 clears circulating hepatitis B virus (HBV) surface antigen (HBsAg),
enhancing the restoration of functional control of HBV infection by immunotherapy. We …
enhancing the restoration of functional control of HBV infection by immunotherapy. We …
[HTML][HTML] Cellular immunity in COVID-19 convalescents with PCR-confirmed infection but with undetectable SARS-CoV-2–specific IgG
S Schwarzkopf, A Krawczyk, D Knop… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We investigated immune responses against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who …
2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who …
Safety and efficacy of 48 weeks REP 2139 or REP 2165, tenofovir disoproxil, and pegylated interferon alfa-2a in patients with chronic HBV infection naïve to nucleos (t …
…, T Musteata, A Jucov, U Dittmer, A Krawczyk… - Gastroenterology, 2020 - Elsevier
Background & Aims Nucleic acid polymers (NAPs) inhibit assembly and secretion of hepatitis
B virus (HBV) subviral particles. We performed an open-label, phase 2 study of the safety …
B virus (HBV) subviral particles. We performed an open-label, phase 2 study of the safety …
[HTML][HTML] Rapid quantification of SARS-CoV-2-neutralizing antibodies using propagation-defective vesicular stomatitis virus pseudotypes
…, T Vollmer, B Fischer, J Steinmann, A Krawczyk… - Vaccines, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2, a new member of the
genus Betacoronavirus, is a pandemic virus, which has caused numerous fatalities, …
genus Betacoronavirus, is a pandemic virus, which has caused numerous fatalities, …
[HTML][HTML] Turmeric root and its bioactive ingredient curcumin effectively neutralize SARS-CoV-2 in vitro
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2) is the causative
agent of the coronavirus disease 2019 (COVID-19). The availability of effective and well-…
agent of the coronavirus disease 2019 (COVID-19). The availability of effective and well-…